Stock 4131 NEOCORE TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials NeoCore Technology Co., Ltd.

Equities

4131

TW0004131008

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
31.25 TWD +0.48% Intraday chart for NeoCore Technology Co., Ltd. +0.97% +42.05%
Mar. 15 NeoCore Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 DR. Chip Biotechnology Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 362.2 221.2 308.6 313.9 389.5 869
Enterprise Value (EV) 1 347.7 220 315.7 376.7 463.3 672.6
P/E ratio -13.8 x -18.3 x -11.4 x -18.2 x -13.8 x -11.8 x
Yield - - - - - -
Capitalization / Revenue 5.86 x 2.12 x 3.31 x 3.53 x 4.38 x 13.4 x
EV / Revenue 5.63 x 2.11 x 3.38 x 4.24 x 5.21 x 10.4 x
EV / EBITDA -15.5 x -14.3 x -10.7 x -15.4 x -12.9 x -8.42 x
EV / FCF -5.1 x -38.4 x -15.4 x -29.3 x 53.2 x -14.1 x
FCF Yield -19.6% -2.6% -6.51% -3.41% 1.88% -7.07%
Price to Book 2.24 x 1.47 x 2.39 x 2.8 x 5.13 x 2.5 x
Nbr of stocks (in thousands) 19,000 19,000 19,000 19,000 19,000 39,500
Reference price 2 19.06 11.64 16.24 16.52 20.50 22.00
Announcement Date 3/30/19 3/23/20 3/31/21 3/30/22 3/29/23 3/15/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 61.79 104.5 93.34 88.93 88.97 64.73
EBITDA 1 -22.42 -15.35 -29.52 -24.47 -35.78 -79.84
EBIT 1 -26.28 -19.25 -33.43 -28.33 -40.33 -84.94
Operating Margin -42.53% -18.43% -35.82% -31.85% -45.33% -131.23%
Earnings before Tax (EBT) 1 -25.22 -11.86 -28.93 -23.78 -38.48 -82.09
Net income 1 -25.07 -11.86 -27.1 -17.2 -28.22 -64.64
Net margin -40.57% -11.36% -29.03% -19.34% -31.71% -99.87%
EPS 2 -1.378 -0.6354 -1.426 -0.9100 -1.490 -1.870
Free Cash Flow 1 -68.2 -5.725 -20.56 -12.85 8.702 -47.55
FCF margin -110.37% -5.48% -22.03% -14.45% 9.78% -73.46%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/30/19 3/23/20 3/31/21 3/30/22 3/29/23 3/15/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 7.1 62.8 73.8 -
Net Cash position 1 14.5 1.23 - - - 196
Leverage (Debt/EBITDA) - - -0.2404 x -2.567 x -2.063 x -
Free Cash Flow 1 -68.2 -5.72 -20.6 -12.9 8.7 -47.6
ROE (net income / shareholders' equity) -18% -7.61% -19.9% -18.4% -38.8% -38%
ROA (Net income/ Total Assets) -8.91% -4.76% -7.68% -6.24% -9.19% -13%
Assets 1 281.3 249.4 352.7 275.6 307.1 496.5
Book Value Per Share 2 8.520 7.900 6.800 5.900 4.000 8.800
Cash Flow per Share 2 2.870 1.580 1.500 0.5500 2.120 7.430
Capex - 0.4 0.23 - 0.74 11.3
Capex / Sales - 0.38% 0.25% - 0.83% 17.38%
Announcement Date 3/30/19 3/23/20 3/31/21 3/30/22 3/29/23 3/15/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Equipment

1st Jan change Capi.
NEOCORE TECHNOLOGY CO., LTD. Stock NeoCore Technology Co., Ltd.
+42.05% 38.08M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+75.35% 12.54B
PENUMBRA, INC. Stock Penumbra, Inc.
-23.01% 7.39B
MASIMO CORPORATION Stock Masimo Corporation
+8.35% 6.62B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+14.40% 5.43B
APT MEDICAL INC. Stock APT Medical Inc.
+32.74% 4.81B
GETINGE AB Stock Getinge AB
-14.85% 4.8B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-25.57% 3.72B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-23.06% 2.76B
NOVOCURE LIMITED Stock NovoCure Limited
+55.06% 2.4B
Medical Equipment
  1. Stock Market
  2. Equities
  3. 4131 Stock
  4. Financials NeoCore Technology Co., Ltd.